Changes of NLF in Serum of Long COVID Patients

Sponsor

University Hospital, Bonn (Other)

Overall Status

Recruiting

CT.gov ID

NCT05060692

Collaborator

(none)

Enrollment

Location

Anticipated Duration (Months)

1.8

Patients Per Site Per Month

Study Details

Study Description

Brief Summary

The study investigates the serum NFL levels in Long-COVID patients.

Condition or Disease	Intervention/Treatment	Phase
Clinical Syndrome	Diagnostic Test: Bloot testing

Detailed Description

The study investigates the serum NFL levels in Long-COVID patients.

Study Design

Study Type:

Observational

Anticipated Enrollment :

30 participants

Observational Model:

Case-Control

Time Perspective:

Prospective

Official Title:

Changes of NLF in Serum of Long COVID Patients

Actual Study Start Date :

Jun 1, 2020

Anticipated Primary Completion Date :

Oct 31, 2021

Anticipated Study Completion Date :

Oct 31, 2021

Arms and Interventions

Arm	Intervention/Treatment
LONGCOVID Patient with Long-COVID Syndrom	Diagnostic Test: Bloot testing NFL measruments in serum
CONTROLS Healthy individials	Diagnostic Test: Bloot testing NFL measruments in serum

Arm

Intervention/Treatment

LONGCOVID

Patient with Long-COVID Syndrom

Diagnostic Test: Bloot testing

NFL measruments in serum

CONTROLS

Healthy individials

Diagnostic Test: Bloot testing

NFL measruments in serum

Outcome Measures

Primary Outcome Measures

Levels of NFL over a 1 year course of the Long-COVID Syndrom [1 year]
see above

Eligibility Criteria

Criteria

Ages Eligible for Study:

18 Years to 100 Years

Sexes Eligible for Study:

All

Accepts Healthy Volunteers:

Yes

Long-COVID Syndrom

Contacts and Locations

Locations

	Site	City	State	Country	Postal Code
1	Laura de Boni	Bonn		Germany	53105

Sponsors and Collaborators

University Hospital, Bonn

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.

Responsible Party:

Laura de Boni, Gabor Petzold, Dr., University Hospital, Bonn

ClinicalTrials.gov Identifier:

NCT05060692

Other Study ID Numbers:

First Posted:

Sep 29, 2021

Last Update Posted:

Sep 29, 2021

Last Verified:

Sep 1, 2021

Individual Participant Data (IPD) Sharing Statement:

Plan to Share IPD:

Studies a U.S. FDA-regulated Drug Product:

Studies a U.S. FDA-regulated Device Product:

Study Results

No Results Posted as of Sep 29, 2021